SCHEMBL3852755

SCHEMBL3852755

O=C(c1ccc(Cl)cc1)N1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 8/20 0.70
CLK4 Q9HAZ1 4/20 0.48
CYP3A4 P08684 2/20 0.48
HIF1A Q16665 1/20 0.48
HSD17B10 Q99714 3/20 0.48
TSHR P16473 2/20 0.48
USP2 O75604 1/20 0.48
SLC6A7 Q99884 1/20 0.46
MAPK7 Q13164 1/20 0.46
MAPKAPK2 P49137 1/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 1/20 0.46
CYP2D6 P10635 1/20 0.46
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
STAT3 P40763 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845918 0.85 CLK4 (0.54) AKT1CLK4CYP3A4HIF1AHSD17B10
Trifluoroacetic Acid SCHEMBL3847292 0.83 AKT1 (0.65) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3849396 0.83 AKT1 (0.50) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3855266 0.81 AKT1 (0.59) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3852545 0.80 AKT1 (0.48) AKT1CLK4CYP3A4HIF1AHSD17B10
Hydrochloric Acid SCHEMBL3851636 0.79 AKT1 (0.58) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3850109 0.78 CYP3A4 (0.65) AKT1CLK4CYP3A4HIF1AHSD17B10
Trifluoroacetic Acid SCHEMBL3844998 0.78 USP2 (0.52) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3854046 0.78 AKT1 (0.56) AKT1CLK4CYP3A4HIF1AHSD17B10
SCHEMBL3867694 0.78 AKT1 (0.58) AKT1CLK4CYP3A4HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed